-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Oruka Therapeutics, Raises Price Target to $72

Benzinga·03/13/2026 14:29:16
Listen to the news
Stifel analyst Alex Thompson maintains Oruka Therapeutics (NASDAQ:ORKA) with a Buy and raises the price target from $47 to $72.